Copyright
©The Author(s) 2020.
World J Diabetes. Jan 15, 2020; 11(1): 1-12
Published online Jan 15, 2020. doi: 10.4239/wjd.v11.i1.1
Published online Jan 15, 2020. doi: 10.4239/wjd.v11.i1.1
Complement protein | Obesity | Insulin resistance | Diabetes |
C3 | Increases adipose tissue inflammation[45,46]; Highly expressed in adipose tissue[70,71] | Marker of insulin resistance[42] | Proinflammatory cytokine causing systemic low-grade inflammation, insulin resistance and impaired glucose uptake[67-69]; Link between inflammation and thrombosis[75,76]; Higher concentrations associated with increased risk of diabetic complications[86] |
C3a and C3aR | Increased levels of C3 in obese individuals[43,47,48]; Increased C3aR in white adipose tissue[49] | Improved glucose tolerance and insulin resistance in C3aR-/- mice[54,55,84] | Proinflammatory cytokine enhanced by cross-talk with TLR4 and C3[45,46]; C3a augments insulin secretion from mouse pancreatic beta cells[83] |
C3adesArg (ASP) | Increased levels found in obese individuals[14,53]; Obesity induced adipose tissue creates this product leading to a pro-inflammatory state and ASP resistance[55] | Insulin-like properties by stimulating uptake of glucose and synthesis of triglycerides in adipose tissue[55] | Stimulating glucose uptake and lipid storage in adipose tissue[70,71]; Plays a role in chronic inflammation and contribute to microvascular complications[87] |
C5a and C5aR | Expressed in adipocytes[49]; Play role in adipose tissue biology and development of metabolic disorders | Affect coagulation and contribute to inflammation[22-27] | |
Factor I and H | Increased in adipose tissue, activated by complement activation and affecting adipose tissue biology[41,42] | ||
sC5b-9 and MASP-2 | Elevated in T2DM; Contributing to endothelial dysfunction and ROS production in diabetes pathophysiology[62,95-97]; MASP-2 contributes to complications of diabetes[94] | ||
CD 59 and MAC | Decreased levels of CD 59 in diabetics[62]; Increased levels of MAC found in diabetic patients and contributes to pathophysiology of complications[62,95-97] |
- Citation: Shim K, Begum R, Yang C, Wang H. Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus. World J Diabetes 2020; 11(1): 1-12
- URL: https://www.wjgnet.com/1948-9358/full/v11/i1/1.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i1.1